Minimally invasive versus conventional extracorporeal circulation circuits in patients undergoing coronary artery bypass surgery: a propensity-matched analysis
暂无分享,去创建一个
S. Saha | H. Niehaus | H. Baraki | I. Kutschka | Ammar Ahmad | S. Varghese | C. Ulrich | M. Leistner | M. Herr
[1] J. Schaarschmidt,et al. Is 300 Seconds ACT Safe and Efficient during MiECC Procedures? , 2017, The Thoracic and Cardiovascular Surgeon.
[2] S. Fichtlscherer,et al. Patient Blood Management in der Herzchirurgie , 2017, Zeitschrift für Herz-,Thorax- und Gefäßchirurgie.
[3] J. Schaarschmidt,et al. Use of minimal invasive extracorporeal circulation in cardiac surgery: principles, definitions and potential benefits. A position paper from the Minimal invasive Extra-Corporeal Technologies international Society (MiECTiS). , 2016, Interactive cardiovascular and thoracic surgery.
[4] G. Angelini,et al. Liberal or restrictive transfusion after cardiac surgery. , 2015, The New England journal of medicine.
[5] A. Haidich,et al. Use of minimal extracorporeal circulation improves outcome after heart surgery; a systematic review and meta-analysis of randomized controlled trials. , 2013, International journal of cardiology.
[6] B. Spiess,et al. Blood product conservation is associated with improved outcomes and reduced costs after cardiac surgery. , 2013, The Journal of thoracic and cardiovascular surgery.
[7] T. Hájek,et al. A prospective randomised multicentre clinical comparison of a minimised perfusion circuit versus conventional cardiopulmonary bypass. , 2010, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.
[8] H. Vohra,et al. Mini extracorporeal circuit cardiopulmonary bypass system: a review , 2010, Perfusion.
[9] R. Whistance,et al. The Inflammatory Response to Miniaturised Extracorporeal Circulation: A Review of the Literature , 2010, Mediators of inflammation.
[10] Chris A Rogers,et al. Increased Mortality, Postoperative Morbidity, and Cost After Red Blood Cell Transfusion in Patients Having Cardiac Surgery , 2007, Circulation.
[11] G. Angelini,et al. Indications for blood transfusion in cardiac surgery. , 2006, The Annals of thoracic surgery.
[12] T. Mihaljevic,et al. Transfusion in coronary artery bypass grafting is associated with reduced long-term survival. , 2006, The Annals of thoracic surgery.
[13] D. Holt,et al. In vivo comparison study of FDA-approved surface-modifying additives and poly-2-methoxyethylacrylate circuit surfaces coatings during cardiopulmonary bypass. , 2006, The journal of extra-corporeal technology.
[14] J. Albes,et al. Comparison of minimally invasive closed circuit extracorporeal circulation with conventional cardiopulmonary bypass and with off-pump technique in CABG patients: selected parameters of coagulation and inflammatory system. , 2005, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.
[15] O. Ponzio,et al. Reduction of the inflammatory response following coronary bypass grafting with total minimal extracorporeal circulation. , 2002, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.
[16] A. Mochizuki,et al. Blood compatible aspects of poly(2-methoxyethylacrylate) (PMEA)--relationship between protein adsorption and platelet adhesion on PMEA surface. , 2000, Biomaterials.
[17] Y. Tomizawa,et al. Comparative study of biocompatibility between the open circuit and closed circuit in cardiopulmonary bypass. , 1999, Artificial organs.
[18] Raed A. Alsatli. Mini cardiopulmonary bypass: Anesthetic considerations , 2012, Anesthesia, essays and researches.
[19] Journal of Cardiothoracic Surgery BioMed Central , 2007 .